八段锦用于缺血性心力衰竭患者II期心脏康复(BEAR试验):一项前瞻性随机对照试验的研究方案
BEAR试验为前瞻性随机对照试验,计划纳入120例冠心病所致慢性心力衰竭患者,按1:1随机分为八段锦联合常规心脏康复运动组与单纯常规运动组。八段锦组在常规运动基础上每周2次、每次45分钟、持续12周;主要结局为6分钟步行试验步行距离。该试验旨在评估八段锦作为标准治疗辅助手段对心肺功能、运动耐量和生活质量的影响。
要点
- 八段锦联合常规心脏康复运动,每周2次、每次45分钟、持续12周。
- 主要结局为6分钟步行试验步行距离;次要结局涵盖VO2 peak、VAT、LVEF、MLHFQ等。
- 这是首个评估八段锦用于缺血性心衰患者II期心脏康复的随机对照试验。
核心结论
- 八段锦作为标准治疗的辅助手段对冠心病所致慢性心力衰竭患者心肺功能、运动耐量和生活质量的影响尚待该试验验证。
研究设计与样本
- 前瞻性随机对照试验,计划纳入120例冠心病所致慢性心力衰竭患者,按1:1随机分为八段锦联合常规心脏康复运动组与单纯常规心脏康复运动组。
主要发现
- 八段锦组在常规体力活动外,每周进行2次、每次45分钟的八段锦训练,持续12周。
- 主要结局为6分钟步行试验(6MWT)步行距离。
- 次要结局包括峰值摄氧量(VO2 peak)、通气无氧阈(VAT)、VE/VCO2斜率、左心室舒张末期容积指数(LVEDVi)、左心室射血分数(LVEF)、明尼苏达心衰生活质量问卷(MLHFQ)评分、NT-proBNP、hs-CRP、心率变异性(HRV)、NYHA分级和主要不良心血管事件。
临床怎么用
- 若试验成功,可证明八段锦运动在改善缺血性心衰患者II期心脏康复中心肺功能与运动耐量的价值,并可能形成基于中医气功的心脏康复框架。
局限性
- 该试验为研究方案,尚未报告结果;试验注册为回顾性注册(2017年7月23日)。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Preliminary evidence based on clinical observations suggests that meditative exercise may offer potential benefits for patients with chronic heart failure (CHF). Cardiac rehabilitation (CR), as a class-IA indication in clinical practice guidelines, has been established as an effective strategy to improve quality of life and prognosis of CHF patients. Baduanjin exercise is an important component of traditional Chinese Qigong exercises. However, its benefits for CHF have not been rigorously tested. We sought to investigate whether Baduanjin, as an adjunct to standard care, improves cardiopulmonary function, exercise tolerance, and quality of life in patients with CHF caused by coronary artery disease (CAD). METHODS/DESIGN: In this randomized controlled trial, 120 patients will be randomly allocated in a 1:1 ratio to Baduanjin exercise combined with conventional exercise of CR (Baduanjin exercise group) or conventional exercise of CR alone (conventional exercise group). In addition to conventional physical activity, participants in the Baduanjin exercise group will participate in a 45-min Baduanjin exercise training session twice a week, for 12 weeks. The primary outcome is walking distance in the 6-min Walk Test (6MWT), and the secondary outcomes are peak oxygen uptake (VO2 peak), ventilatory anerobic threshold (VAT), The minute ventilation to carbon dioxide production relationship (VE/VCO2 slope), left ventricular end-diastolic volume index (LVEDVi), left ventricular ejection fraction (LVEF), quality of life assessed by the Minnesota Living with Heart Failure Questionnaire (MLHFQ), amino-terminal pro-brain natriuretic peptide (NT-proBNP), hs-CRP, heart rate variability (HRV), New York Heart Association (NYHA) classification, and major adverse cardiovascular events. DISCUSSION: This is the first trial to evaluate the effects of a Baduanjin exercise-based CR program on cardiopulmonary function and exercise tolerance in ischemic CHF patients. If successful, it will prove the value of Baduanjin exercise in improving cardiopulmonary function and exercise tolerance in patients with ischemic heart failure on phase-II CR, and may further develop a Chinese Qigong exercise-based CR framework. TRIAL REGISTRATION: ClinicalTrials.gov, ID: NCT03229681 . Registered retrospectively on 23 July 2017.
引用
- Yu M, Li S, Li S, et al. Baduanjin exercise for patients with ischemic heart failure on phase-II cardiac rehabilitation (BEAR trial): study protocol for a prospective randomized controlled trial. Trials. 2018. PMID: 30012193. doi:10.1186/s13063-018-2759-4
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。